Collectively, these data demonstrate that YAP and its target genes (Bcl-xl, CTGF, Cyr61) play important roles in the progression of human HCC, and their expression levels were highly correlated with poor prognosis. This evidence concerns the gene CCN1 and hepatocellular carcinoma.